The authors review gut dysfunction and microbiota changes during HIV infection and IBD and discuss how they may induce a dysfunctional mucosal barrier, dysbiosis, and changes on the cellular level, including monocytes, macrophages, and dendritic cells.
Researchers sought to identify disparities in the care and outcomes of patients with IBD of differing races and ethnicities, in order to improve health care equity.
High volume defined by annual number of complex gastrointestinal cancer-related surgery procedures of interest supported by that anesthesiologist in two years before the index surgery
Researchers investigated whether psychological comorbidities predated the diagnosis and propagation of inflammatory bowel disease.
A team of investigators conducted a systematic review and meta-analysis to assess the risk of extraintestinal cancer in patients with inflammatory bowel disease.
Patients who undergo RYGB are less likely to need antihypertensive medications at 3 years compared with those who manage their blood pressure with medical therapy alone.
Is treatment of inflammatory bowel disease (IBD) with biologic therapies harmful during infection with COVID-19?
Treatments guided by metagenomics may result in symptom improvement for patients with irritable bowel syndrome.
Although cannabis use does not induce clinical remission in IBD, patient-reported quality of life may improve.
An AI-powered, fully automated video analysis system may potentially provide endoscopic disease grading in ulcerative colitis that is equal to the scoring of experienced reviewers.
